Pay in 4 interest-free payments of $14.00 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors
Tofacitinib
Formula: C22H34O7
and induces p53-dependent apoptosis in p53 wild type and null isogenic cancer cell lines
Many tumors become addicted to autophagy for survival
PF-04979064 - PI3K/mTOR Dual Inhibitor. CAS# 1220699-06-8 hylase The RAD51-stimulatory compound RS-1 canPF 04979064, CAS No. 1220699 06 8, is a highly potent and orally bioavailable PI3K mTOR dual inhibitor developed through structure based drug design. It inhibited mTOR, PI3K, , and isoforms and AKT phosphorylation with IC50 as 2. 64 nM, 0. 395 nM, 0. 111 nM, 0. 122 nM and 28. 3 nM, respectively. PF 04979064 exhibited cellular potency with an IC50 of 9. 1 nM in a BT20 cell assay. PF 04979064 exhibited excellent in vitro potency, very good solubility,
US$ 20.00
US$ 30.00
US$ 99.00
US$ 18.00
US$ 79.95
US$ 15.90
US$ 10.00
US$ 99.00